Literature DB >> 17275557

A clinico-pathological study of laryngeal and hypopharyngeal carcinoma: correlation of cord-arytenoid mobility with histopathologic involvement.

Hüseyin Katilmiş1, Sedat Oztürkcan, Ismail Ozdemir, Işil Adadan, Aziz Tunç, Ayşegül Akder, Sinan Başoğlu.   

Abstract

OBJECTIVE: This study evaluates the vocal cord and arytenoid mobility in relation to the tumoral involvement of the cricoarytenoid joint (CAJ), thyroarytenoid (TA) muscle, and posterior cricoarytenoid (PCA) muscle in whole-organ sections of total laryngectomy specimens. STUDY DESIGN AND
SETTING: The study was prospectively carried out between 1998 and 2003 and involved 133 primary squamous cell carcinoma cases of larynx or pyriform sinus that were treated with total laryngectomy. Preoperative mobility of vocal cords and arytenoids were evaluated separately and correlated with histopathologic findings.
RESULTS: In cases with fixed vocal cord CAJ, TA muscle, and PCA muscle were involved in 42.4%, 72.9%, and 27.1% of the cases, respectively, while in cases with fixed arytenoid these structures were affected in 40%, 66.3%, and 25.3% of the cases. Weight effect seemed to play a role in 60% and 50% of the cases of supraglottic and pyriform sinus carcinoma, respectively.
CONCLUSION: Careful evaluation of the mobility of the cord arytenoid unit separately helps the surgeon to better understand the patterns of tumoral extension guiding for the appropriate surgery which should be undertaken.

Entities:  

Mesh:

Year:  2007        PMID: 17275557     DOI: 10.1016/j.otohns.2006.08.022

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  8 in total

1.  [The value of supracricoid partial laryngectomy in moderately advanced laryngeal cancer (T3-T4a)].

Authors:  U Schroeder; B Wollenberg; K L Bruchhage
Journal:  HNO       Date:  2015-11       Impact factor: 1.284

2.  Asymmetric mineralization of the arytenoid cartilages in patients without laryngeal cancer.

Authors:  E Zan; D M Yousem; N Aygun
Journal:  AJNR Am J Neuroradiol       Date:  2011-04-14       Impact factor: 3.825

Review 3.  Nomenclature proposal to describe vocal fold motion impairment.

Authors:  Clark A Rosen; Ted Mau; Marc Remacle; Markus Hess; Hans E Eckel; VyVy N Young; Anastasios Hantzakos; Katherine C Yung; Frederik G Dikkers
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-06-03       Impact factor: 2.503

4.  Posttreatment Non-Improved Vocal Cord Mobility Indicates the Need of Salvage Surgery for Hypopharyngeal Carcinomas.

Authors:  Yu-Qin He; Xi-Wei Zhang; Yi-Ming Zhu; Xiao-Guang Ni; Ze-Hao Huang; Chang-Ming An; Jun-Lin Yi; Shao-Yan Liu
Journal:  Front Oncol       Date:  2021-01-08       Impact factor: 6.244

5.  Prognostic value of computed tomography scan detection of cartilage invasion in advanced laryngeal cancer treated with primary total laryngectomy.

Authors:  Maxwell Y Lee; Jonathan Lee; Sarah Stock; Mario Belfiglio; Brian Matia; Shlomo Koyfman; Nikhil P Joshi; Brian B Burkey; Eric Lamarre; Brandon Prendes; Joseph Scharpf; Robert R Lorenz; Neil M Woody; David J Adelstein; Jessica L Geiger; Deborah J Chute; Jamie A Ku
Journal:  Head Neck       Date:  2022-07-08       Impact factor: 3.821

6.  Traditional transcutaneous approaches in head and neck surgery.

Authors:  Ulrich R Goessler
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-12-20

7.  Prognostic Significance of Vocal Cord Mobility after Laryngeal Preservation Protocols in Locally Advanced Laryngopharyngeal Cancers: A Retrospective Analysis.

Authors:  Vishal U S Rao; Kinjal Shankar Majumdar; Anand Subash; Nabanita Banerjee; Piyush Sinha; Rachana Prasad; Akshay Kudpaje; Ravi C Nayar
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2021-02-08

8.  The thyro-cricoarytenoid space (TCAS): clinical and prognostic implications in laryngeal cancer.

Authors:  Marco Lucioni; Marco Lionello; Francesco Guida; Federica Sovran; Fabio Canal; Giuseppe Rizzotto; Andy Bertolin
Journal:  Acta Otorhinolaryngol Ital       Date:  2020-04       Impact factor: 2.124

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.